A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma
NCT03809637
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
Pemetrexed, cisplatin
Sponsor
Yonsei University